Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a phase I dose escalating study of oral satraplatin in combination with Abraxane
administered weekly for three out of every four weeks in patients with advanced solid
cancers.